ATE78814T1 - Thioformamidderivate. - Google Patents

Thioformamidderivate.

Info

Publication number
ATE78814T1
ATE78814T1 AT90400016T AT90400016T ATE78814T1 AT E78814 T1 ATE78814 T1 AT E78814T1 AT 90400016 T AT90400016 T AT 90400016T AT 90400016 T AT90400016 T AT 90400016T AT E78814 T1 ATE78814 T1 AT E78814T1
Authority
AT
Austria
Prior art keywords
aryl
alkyl
carbamoyl
represents hydrogen
arylco
Prior art date
Application number
AT90400016T
Other languages
English (en)
Inventor
Malcolm Norman Palfreyman
Nigel Vicker
Roger John Aitchison Walsh
Original Assignee
May & Baker Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB898900245A external-priority patent/GB8900245D0/en
Priority claimed from GB898900295A external-priority patent/GB8900295D0/en
Application filed by May & Baker Ltd filed Critical May & Baker Ltd
Application granted granted Critical
Publication of ATE78814T1 publication Critical patent/ATE78814T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/56—Amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D215/14—Radicals substituted by oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyridine Compounds (AREA)
  • Organic Insulating Materials (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Separation, Recovery Or Treatment Of Waste Materials Containing Plastics (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Steroid Compounds (AREA)
AT90400016T 1989-01-06 1990-01-04 Thioformamidderivate. ATE78814T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB898900245A GB8900245D0 (en) 1989-01-06 1989-01-06 New compositions of matter
GB898900295A GB8900295D0 (en) 1989-01-06 1989-01-06 New compositions of matter
EP90400016A EP0377532B1 (de) 1989-01-06 1990-01-04 Thioformamidderivate

Publications (1)

Publication Number Publication Date
ATE78814T1 true ATE78814T1 (de) 1992-08-15

Family

ID=26294807

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90400016T ATE78814T1 (de) 1989-01-06 1990-01-04 Thioformamidderivate.

Country Status (16)

Country Link
US (1) US5104883A (de)
EP (1) EP0377532B1 (de)
JP (1) JPH02258760A (de)
KR (1) KR900011727A (de)
AT (1) ATE78814T1 (de)
AU (1) AU4761290A (de)
CA (1) CA2007281A1 (de)
DE (1) DE69000224T2 (de)
DK (1) DK0377532T3 (de)
ES (1) ES2043294T3 (de)
FI (1) FI900056A7 (de)
GR (1) GR3005616T3 (de)
HU (1) HUT53615A (de)
IL (1) IL92930A0 (de)
OA (1) OA09434A (de)
PT (1) PT92796A (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9000342D0 (en) * 1990-01-08 1990-03-07 May & Baker Ltd New compositions of matter
GB9002879D0 (en) * 1990-02-08 1990-04-04 May & Baker Ltd New compositions of matter
WO1993008168A1 (fr) * 1991-10-14 1993-04-29 Eisai Co., Ltd. Derive de thioformamide

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2100970B1 (de) * 1970-07-30 1975-08-01 Fujisawa Pharmaceutical Co

Also Published As

Publication number Publication date
GR3005616T3 (de) 1993-06-07
EP0377532A1 (de) 1990-07-11
OA09434A (en) 1992-10-15
DK0377532T3 (da) 1992-09-14
DE69000224T2 (de) 1993-01-14
HUT53615A (en) 1990-11-28
PT92796A (pt) 1990-07-31
US5104883A (en) 1992-04-14
ES2043294T3 (es) 1993-12-16
DE69000224D1 (en) 1992-09-03
FI900056A0 (fi) 1990-01-05
KR900011727A (ko) 1990-08-02
JPH02258760A (ja) 1990-10-19
EP0377532B1 (de) 1992-07-29
AU4761290A (en) 1990-07-12
CA2007281A1 (en) 1990-07-06
HU900050D0 (en) 1990-03-28
IL92930A0 (en) 1990-09-17
FI900056A7 (fi) 1990-07-07

Similar Documents

Publication Publication Date Title
ATE283259T1 (de) 1,4-substituierte cyclische aminderivate
KR900009660A (ko) 신규 화합물들
FI904602A0 (fi) Pyrazoloderivat, foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska blandningar.
DE69207017D1 (de) Benzamide
DK0378518T3 (da) Adenosinderivater med farmaceutisk aktivitet som antihypertensiva
ES2091212T3 (es) Compuestos de xantina.
ES2168383T3 (es) Derivados de 1,2,3,4-tetrahidroquinoxalindiona y su utilizacion como antagonistas del glutamato receptor.
AU579872B2 (en) 2-amino-4-substituted oxazolines
ATE92489T1 (de) Imid-derivate, ihre herstellung und verwendung.
NO895023D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive aminderivater.
DK0377532T3 (da) Thioformamidderivater
ES2262504T3 (es) Derivados del acido piroglutamico y compuestos afines que inhiben la adhesion de leucocitos mediada por la vla-4.
IL141114A0 (en) NOVEL C-2 S/O- AND S/N FORMALDEHYDE ACETAL DERIVATIVES OF CARBAPENEM-3-CARBOXYLIC ACIDS AND THEIR USE AS ANTIBIOTICS AND β-LACTAMASE INHIBITORS
IL83216A (en) 1((5-(10->9)abeo-6-methylergolin-8beta-yl)methyl)-imidazolidine-(and hexahydropyrimidine)-2,4-dione derivatives,their preparation and pharmaceutical compositions containing them
ES2116508T3 (es) Procedimiento para la preparacion de 2-perfluoroalquil-3-oxazolin-5-ona.
DE69714709D1 (de) Cyclische amic-säurederivate

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee